AIMS/HYPOTHESIS: Proinflammatory cytokines, including IL-1, exert pleiotropic effects on the neuro-immuno-endocrine system. Previously, we showed that mice with knockout of the gene encoding IL-1 receptor antagonist (Il1ra (-/-), also known as Il1rn (-/-)) have a lean phenotype. The present study was designed to analyse the mechanisms leading to this lean phenotype. METHODS: Il1ra (-/-) mice were fed a high-fat diet following weaning. Energy expenditure, body temperature, heart rate, blood parameters, urinary catecholamines and adipose tissue were analysed. RESULTS: Il1ra (-/-) mice exhibited resistance to obesity induced by a high-fat diet; this resistance was associated with increased energy expenditure and a decreased respiratory quotient, indicating that the ratio of fat:carbohydrate metabolism in Il1ra (-/-) mice is greater than in controls. Activity level in Il1ra (-/-) mice was significantly decreased and body temperature was significantly increased, compared with wild-type (WT) mice. Inguinal white adipose tissues in Il1ra (-/-) mice express increased levels of Ucp1 and mitochondrial respiratory chain genes compared with WT mice. Histological analysis of adipose tissue in Il1ra (-/-) mice revealed that brown adipose tissue is hyperactive and inguinal white adipose tissue contains smaller cells, which exhibit the distinctive multilocular appearance of brown adipocytes. Urinary epinephrine and norepinephrine excretion in Il1ra (-/-) mice was significantly increased compared with WT mice, suggesting that Il1ra (-/-) mice have increased sympathetic tone. Consistent with this, heart rate in Il1ra (-/-) mice was also significantly increased. CONCLUSIONS/ INTERPRETATION: Our results show that Il1ra (-/-) mice have increased energy expenditure, fat:carbohydrate oxidation ratio, body temperature, heart rate and catecholamine production. All of these observations are consistent with an enhanced sympathetic tone.
AIMS/HYPOTHESIS: Proinflammatory cytokines, including IL-1, exert pleiotropic effects on the neuro-immuno-endocrine system. Previously, we showed that mice with knockout of the gene encoding IL-1 receptor antagonist (Il1ra (-/-), also known as Il1rn (-/-)) have a lean phenotype. The present study was designed to analyse the mechanisms leading to this lean phenotype. METHODS:Il1ra (-/-) mice were fed a high-fat diet following weaning. Energy expenditure, body temperature, heart rate, blood parameters, urinary catecholamines and adipose tissue were analysed. RESULTS:Il1ra (-/-) mice exhibited resistance to obesity induced by a high-fat diet; this resistance was associated with increased energy expenditure and a decreased respiratory quotient, indicating that the ratio of fat:carbohydrate metabolism in Il1ra (-/-) mice is greater than in controls. Activity level in Il1ra (-/-) mice was significantly decreased and body temperature was significantly increased, compared with wild-type (WT) mice. Inguinal white adipose tissues in Il1ra (-/-) mice express increased levels of Ucp1 and mitochondrial respiratory chain genes compared with WT mice. Histological analysis of adipose tissue in Il1ra (-/-) mice revealed that brown adipose tissue is hyperactive and inguinal white adipose tissue contains smaller cells, which exhibit the distinctive multilocular appearance of brown adipocytes. Urinary epinephrine and norepinephrine excretion in Il1ra (-/-) mice was significantly increased compared with WT mice, suggesting that Il1ra (-/-) mice have increased sympathetic tone. Consistent with this, heart rate in Il1ra (-/-) mice was also significantly increased. CONCLUSIONS/ INTERPRETATION: Our results show that Il1ra (-/-) mice have increased energy expenditure, fat:carbohydrate oxidation ratio, body temperature, heart rate and catecholamine production. All of these observations are consistent with an enhanced sympathetic tone.
Authors: Emmanuel Somm; Elvire Henrichot; Agnès Pernin; Cristiana E Juge-Aubry; Patrick Muzzin; Jean-Michel Dayer; Martin J H Nicklin; Christoph A Meier Journal: Diabetes Date: 2005-12 Impact factor: 9.461
Authors: Nadine S Sauter; Fabienne T Schulthess; Ryan Galasso; Lawrence W Castellani; Kathrin Maedler Journal: Endocrinology Date: 2008-01-31 Impact factor: 4.736
Authors: J A Ehses; G Lacraz; M-H Giroix; F Schmidlin; J Coulaud; N Kassis; J-C Irminger; M Kergoat; B Portha; F Homo-Delarche; M Y Donath Journal: Proc Natl Acad Sci U S A Date: 2009-07-30 Impact factor: 11.205
Authors: Maya E Kotas; Michael J Jurczak; Charles Annicelli; Matthew P Gillum; Gary W Cline; Gerald I Shulman; Ruslan Medzhitov Journal: Proc Natl Acad Sci U S A Date: 2013-03-04 Impact factor: 11.205
Authors: Amina El Ayadi; Ron C Helderman; Celeste C Finnerty; David N Herndon; Clifford J Rosen; Gordon L Klein Journal: Osteoporos Sarcopenia Date: 2019-08-28
Authors: Yakun Ren; Hao Zhao; Chunyan Yin; Xi Lan; Litao Wu; Xiaojuan Du; Helen R Griffiths; Dan Gao Journal: Front Endocrinol (Lausanne) Date: 2022-07-14 Impact factor: 6.055
Authors: Roel Quintens; Sarvjeet Singh; Katleen Lemaire; Katrien De Bock; Mikaela Granvik; Anica Schraenen; Irene Olga Cornelia Maria Vroegrijk; Veronica Costa; Pieter Van Noten; Dennis Lambrechts; Stefan Lehnert; Leentje Van Lommel; Lieven Thorrez; Geoffroy De Faudeur; Johannes Anthonius Romijn; John Michael Shelton; Luca Scorrano; Henri Roger Lijnen; Peter Jacobus Voshol; Peter Carmeliet; Pradeep Puthenveetil Abraham Mammen; Frans Schuit Journal: PLoS One Date: 2013-02-27 Impact factor: 3.240
Authors: Niclas Franck; Michael Maris; Sarah Nalbandian; Saswata Talukdar; Simon Schenk; Hans-Peter Hofmann; David Bullough; Olivia Osborn Journal: PLoS One Date: 2014-09-22 Impact factor: 3.240